Northway Biotechpharma to manufacture Memo’s Covid1-9 drug MTX-COVAB
Memo Therapeutics (MTx), a Swiss biotech company, has entered into a partnership with Northway Biotechpharma, under which the latter will manufacture the former’s MTX-COVAB – ... Read More
AstraZeneca finalizes AZD1222 Covid-19 vaccine candidate deal with EC
AstraZeneca said that it has finalized a deal with the European Commission (EC) for the delivery of up to 400 million doses of the AZD1222 ... Read More
Thermo Fisher scraps $11.5bn Qiagen deal after failed tender offer
Thermo Fisher Scientific has scrapped its previously planned $11.5 billion acquisition of Qiagen after its offer to buy all of the ordinary shares of the ... Read More
Moderna bags $1.5bn contract to supply mRNA-1273 Covid-19 vaccine to US govt
Moderna has bagged a deal worth up to $1.52 billion for the manufacturing and supply of 100 million doses of its mRNA-1273 vaccine candidate for ... Read More
Bayer to acquire KaNDy Therapeutics to add menopause drug candidate
Bayer has agreed to acquire KaNDy Therapeutics, a UK clinical-stage biotech company, in a deal worth up to $900 million, in a move to grow ... Read More
Ligand Pharmaceuticals to acquire protein therapeutics developer Pfenex
US biopharma company Ligand Pharmaceuticals has signed a deal worth up to $516 million to acquire Pfenex, a development and licensing biotechnology company engaged in ... Read More
Kazia Therapeutics gets US RPDD for paxalisib in childhood brain cancer
Kazia Therapeutics, an Australian biotech company, has secured the rare pediatric disease designation (RPDD) for paxalisib (formerly GDC-0084) from the US Food and Drug Administration ... Read More
Olympus Corporation to acquire Arc Medical Design from Norgine
Olympus Corporation, a Japanese optical products company, has agreed to acquire Arc Medical Design, a UK-based subsidiary of Dutch specialist pharma company Norgine for an ... Read More
Pfizer to manufacture Gilead’s Covid-19 drug candidate remdesivir
Pfizer has signed a multi-year agreement with Gilead Sciences to manufacture and supply the latter's investigational antiviral remdesivir for the treatment of Covid-19. Under the ... Read More
Pfizer to manufacture Gilead’s Covid-19 drug candidate remdesivir
Pfizer has signed a multi-year agreement with Gilead Sciences to manufacture and supply the latter’s investigational antiviral remdesivir for the treatment of Covid-19. Under the ... Read More